Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1956 1
1957 1
1959 1
1960 2
1961 3
1962 2
1964 4
1965 3
1966 5
1967 6
1968 10
1969 5
1970 6
1971 8
1972 4
1973 6
1974 3
1975 4
1976 7
1977 11
1978 9
1979 11
1980 14
1981 12
1982 15
1983 17
1984 14
1985 24
1986 25
1987 21
1988 33
1989 25
1990 29
1991 34
1992 40
1993 38
1994 35
1995 35
1996 41
1997 53
1998 59
1999 60
2000 66
2001 58
2002 61
2003 78
2004 74
2005 88
2006 74
2007 88
2008 104
2009 99
2010 89
2011 102
2012 112
2013 139
2014 152
2015 145
2016 178
2017 168
2018 139
2019 134
2020 169
2021 158
2022 153
2023 82

Text availability

Article attribute

Article type

Publication date

Search Results

3,132 results

Results by year

Filters applied: . Clear all
Page 1
BRAF Heterogeneity in Melanoma.
Ito T, Tanaka Y, Murata M, Kaku-Ito Y, Furue K, Furue M. Ito T, et al. Among authors: murata m. Curr Treat Options Oncol. 2021 Feb 8;22(3):20. doi: 10.1007/s11864-021-00818-3. Curr Treat Options Oncol. 2021. PMID: 33558987 Review.
Nectin-4: a Novel Therapeutic Target for Skin Cancers.
Hashimoto H, Tanaka Y, Murata M, Ito T. Hashimoto H, et al. Among authors: murata m. Curr Treat Options Oncol. 2022 Apr;23(4):578-593. doi: 10.1007/s11864-022-00940-w. Epub 2022 Mar 21. Curr Treat Options Oncol. 2022. PMID: 35312963 Review.
Balloon pulmonary angioplasty versus riociguat in inoperable chronic thromboembolic pulmonary hypertension (MR BPA): an open-label, randomised controlled trial.
Kawakami T, Matsubara H, Shinke T, Abe K, Kohsaka S, Hosokawa K, Taniguchi Y, Shimokawahara H, Yamada Y, Kataoka M, Ogawa A, Murata M, Jinzaki M, Hirata K, Tsutsui H, Sato Y, Fukuda K. Kawakami T, et al. Among authors: murata m. Lancet Respir Med. 2022 Oct;10(10):949-960. doi: 10.1016/S2213-2600(22)00171-0. Epub 2022 Aug 1. Lancet Respir Med. 2022. PMID: 35926544 Clinical Trial.
Luminescent Nanomaterials (I).
Chang H, Murata MM, Rho WY, Kim J, Lee JH, Lee SH, Jeong DH, Jun BH. Chang H, et al. Among authors: murata mm. Adv Exp Med Biol. 2021;1309:67-96. doi: 10.1007/978-981-33-6158-4_4. Adv Exp Med Biol. 2021. PMID: 33782869 Review.
Discovery of widespread transcription initiation at microsatellites predictable by sequence-based deep neural network.
Grapotte M, Saraswat M, Bessière C, Menichelli C, Ramilowski JA, Severin J, Hayashizaki Y, Itoh M, Tagami M, Murata M, Kojima-Ishiyama M, Noma S, Noguchi S, Kasukawa T, Hasegawa A, Suzuki H, Nishiyori-Sueki H, Frith MC; FANTOM consortium; Chatelain C, Carninci P, de Hoon MJL, Wasserman WW, Bréhélin L, Lecellier CH. Grapotte M, et al. Among authors: murata m. Nat Commun. 2021 Jun 2;12(1):3297. doi: 10.1038/s41467-021-23143-7. Nat Commun. 2021. PMID: 34078885 Free PMC article.
3,132 results